Related Experiment Video
Updated: Feb 10, 2026

04:56
Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
1.2K
EV, Microvesicles/MicroRNAs and Stem Cells in Cancer
Jacob A Tickner1, Derek J Richard1, Kenneth J O'Byrne2
1Cancer and Ageing Research Program, Translational Research Institute, Queensland University of Technology, Brisbane, QLD, Australia.
Advances in Experimental Medicine and Biology
|May 14, 2018
Summary
Extracellular vesicles (EVs) are key in cancer development and spread. These tiny particles show promise as non-invasive cancer biomarkers and for targeted cancer therapies.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Extracellular vesicles (EVs) play a crucial role in intercellular communication.
- Their involvement in carcinogenesis, immune modulation, and metastasis is increasingly recognized.
- EVs can create a pro-tumor microenvironment.
Purpose of the Study:
- To explore the multifaceted role of EVs in cancer.
- To highlight EVs as potential non-invasive diagnostic and prognostic biomarkers.
- To discuss the therapeutic applications of EVs in cancer treatment.
Main Methods:
- Review of current scientific literature on extracellular vesicles and cancer.
- Analysis of EV characteristics, including nucleic acid, protein, and lipid profiles.
- Discussion of EV detection in bodily fluids and their therapeutic potential.
Main Results:
- EVs regulate immune responses and condition metastatic sites.
- EVs exhibit unique molecular profiles reflective of disease state.
- EVs can be detected non-invasively in bodily fluids.
Conclusions:
- Extracellular vesicles are significant in cancer pathogenesis and progression.
- EVs hold great potential as cancer biomarkers for diagnosis and prognosis.
- EV-based therapies offer a promising avenue for cancer treatment development.
Related Concept Videos
MicroRNAs
24.3K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
MicroRNAs
4.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
4.5K
A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Cancer Stem Cells and Tumor Maintenance
6.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.6K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K

